Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > BUSINESS
BUSINESS
- Four Major Listed Dispensing Pharmacies Post Record Performance in FY2011
May 23, 2012
- Myslee Is Most Prescribed Insomnia Drug: Survey
May 23, 2012
- AnGes MG to Allocate Shares Worth 200 Million Yen to Shionogi to Develop NF-κB Decoy Oligo
May 23, 2012
- 11 Leading Foreign-Affiliated Drug Makers Report 12% Growth in Sales in 2011 Driven by New Drugs
May 23, 2012
- NDA Filed for Anti-Androgen Drug MDV3100 in the US: Astellas
May 23, 2012
- Japan Vaccine to Make All-Out Effort,“Invest All Resources” in Cervical Cancer, Rotavirus Vaccines
May 22, 2012
- Sandoz to Copromote Somatropin with Nipro Pharma
May 22, 2012
- Towa to Review Existing Products for Improved Competitiveness, Starting with 70 APIs
May 22, 2012
- Chugai to Make CNS Its Strategic Field; 3 Compounds in Pipeline: President Kosaka
May 21, 2012
- Operating Profits Up 4.2%, Business Expansion Slows Down in FY2011: Major Generics Manufacturers
May 21, 2012
- Hisamitsu Files for Transdermal Oxybutynin for Overactive Bladder
May 21, 2012
- The Growing Presence of Foreign-Affiliates (3)
May 21, 2012
- “Confident in Usefulness” of Alogliptin: President Hasegawa of Takeda
May 18, 2012
- Ono to Conduct Joint Research with German Pharmaceutical Company Using Affilin Technology
May 18, 2012
- Ishibashi to Become SSP President, Torii to Be Withdrawn from Presidency
May 18, 2012
- Morishita Jintan, AnGes MG Jointly Research and Develop Oral Vaccine
May 18, 2012
- Pfizer Resubmit NDA for Fesoterodine Fumarate in March
May 18, 2012
- Eisai Sets Domestic Sales Forecast for Aricept at 90 Billion Yen on Impact of Generics
May 17, 2012
- Double-Digit Drop in Sales, Profits Reported Due to Patent Expiration of Aricept: Eisai
May 17, 2012
- Nichi-Iko, sanofi-aventis to Copromote Lipitor Generic Aiming at Cumulative Sales of 10 Billion Yen over 5 Years
May 17, 2012
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…